Why This Matters for Your Career
Pfizer is hiring 10 roles related to this product
CEFTRIAXONE (ceftriaxone sodium) by Pfizer is drug. Approved for the following infections, usp is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible isolates of the designated bacteria: lower respiratory tract infections (). First approved in 2014.
Worked on CEFTRIAXONE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Study to Compare Blood Levels of Ceftriaxone Given by Suppository or Injection.
Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy
A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea
A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy
A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy
Pfizer is hiring 10 roles related to this product